Key Updates
EssilorLuxottica shares fell 2.03% since the September 4 report, declining from $152.95 to $149.85, marking a new low in the observed period and extending the YTD decline to -44.48%. The price action continues to be dominated by the ongoing governance crisis, with the most recent news (August 30) detailing an escalation in the family rift over founder Leonardo Del Vecchio's €40 billion estate. Management has responded with an €800 million buyback program announced August 28, yet this has failed to stem the selling pressure, with the stock now down 12.60% over the past month. The investment thesis remains firmly in bearish territory as governance instability and competitive pressures in the eyewear retail market continue to weigh on investor sentiment.
Current Trend
The stock is in a pronounced downtrend, with the 1-month decline of -12.60% accelerating to -31.67% over 6 months and -44.48% YTD. The current price of $149.85 represents a continued breakdown below prior support levels, with each successive report showing lower lows. The buyback announcement provided only a temporary reprieve (the August 28 rebound to $162.70), which has since been fully retracedais and exceeded to the downside. The persistent negative momentum suggests sellers remain in control, with no signs of capitulation or stabilization yet observed in the provided data.
Investment Thesis
The core investment thesis for EssilorLuxottica is under severe pressure due to a confluence of governance, competitive, and legal challenges. The family dispute over the €40 billion estate has created a leadership vacuum at Delfin, the controlling shareholder, impairing strategic decision-making at a critical juncture in the AI smart glasses market. Simultaneously, the company faces intensifying competition from private equity-backed eyewear retailers expanding aggressively in key markets like London, challenging EssilorLuxottica's retail dominance. While the company's underlying fundamentals remain substantial (€28.5 billion in sales and €4.4 billion in operating profits reported last year), the market is clearly discounting the stock heavily due to governance uncertainty and competitive threats.
Thesis Status
The bearish thesis remains fully intact and has strengthened further. The governance crisis has escalated with the heir's exit and the €40 billion rift growing, while the €800 million buyback has proven insufficient to restore investor confidence. The stock has now declined 44.48% YTD, indicating the market is pricing in significant risk premium related to the Delfin deadlock and potential strategic paralysis. The competitive threat from agile, private equity-backed entrants is a structural concern that the company has not yet demonstrated a clear response to. The thesis has not changed; rather, the risks identified in prior reports have materialized more severely.
Key Drivers
• Governance crisis escalation — the €40 billion family rift continues to dominate headlines and distract management from strategic priorities (Bloomberg, Aug 30).
• Management response through buyback — €800 million program announced to bolster the stock, yet it has not arrested the decline (Bloomberg, Aug 28).
• Leadership departures — second heir resignation in 2024 signals deepening internal conflict (Bloomberg, Aug 25).
• Competitive disruption — private equity-backed eyewear brands expanding rapidly across London, challenging incumbents (FT, Aug 18).
• Delfin paralysis — boardroom deadlock over dividends, executive pay, and portfolio strategy, plus legal investigations (FT, Aug 10).
Technical Analysis
The stock is trading at $149.85, down 2.03% since the last report and at its lowest observed level. The price has broken below the prior support around $152.95, with no clear support level visible in the provided data until potentially the $145-$140 zone, though this is speculative. The 1-day decline of -2.03% follows the 5-day decline of -7.13%, indicating accelerating downside momentum. The stock's failure to hold the August 28 rebound (to $162.70) suggests any relief rallies are being sold aggressively. The technical picture is decisively bearish with lower lows across all timeframes and no signs of a reversal pattern emerging.
Bull Case
- Management has demonstrated confidence in the company's value through an €800 million buyback program, signaling commitment to shareholder returns despite governance turmoil (Bloomberg, Aug 28).
- Underlying business fundamentals remain robust, with €4.4 billion in operating profits on €28.5 billion in sales, providing substantial cash flow generation capacity (FT, Aug 18).
- The company's scale — 18,000 stores — represents a significant competitive moat that new entrants will find difficult to replicate, as industry executives note barriers to entry are higher than they appear (FT, Aug 18).
- At a -44.48% YTD decline, the stock may be pricing in excessive pessimism, and the buyback at current levels suggests management believes the stock is undervalued (Bloomberg, Aug 28).
- The company's positioning in the emerging AI smart glasses market remains a strategic opportunity, though management attention is currently diverted by governance issues (Bloomberg, Aug 30).
Bear Case
- The €40 billion family rift is escalating and threatens to paralyze strategic decision-making at a critical time, with the heir's exit highlighting deepening governance dysfunction (Bloomberg, Aug 30).
- Delfin's boardroom deadlock over dividends, executive pay, and portfolio strategy means the controlling shareholder cannot make decisive capital allocation choices, impairing the company's strategic agility (FT, Aug 10).
- The buyback has failed to restore investor confidence, with the stock continuing to decline despite the €800 million program, suggesting deeper concerns than valuation (Bloomberg, Aug 28).
- Private equity-backed competitors like Cubitts, Ace & Tate, and Jimmy Fairly are aggressively expanding and targeting high margins in frames and lenses, directly challenging EssilorLuxottica's retail dominance (FT, Aug 18).
- Legal investigations into Delfin chair Francesco Milleri over alleged market manipulation add to the governance risk and could lead to further leadership instability (FT, Aug 10).